Pattern to Participate in Upcoming Investor Conferences
Senior management will host one-on-one and small group meetings, with live presentations webcast and archived on Pattern’s investor relations website.
- ProMIS Neurosciences Inc. announced today it will participate in multiple June 2026 investor conferences, with CEO Neil Warma presenting at the Jefferies Global Healthcare Conference on Thursday, June 4, 2026, from 11:40 a.m. to 12:10 p.m.
- Specializing in therapeutic antibodies and vaccines, ProMIS targets toxic misfolded proteins in neurodegenerative diseases including Alzheimer's, ALS, frontotemporal dementia, multiple system atrophy, and Parkinson's using its proprietary EpiSelect platform.
- PMN310, the company's lead Alzheimer's disease candidate, is designed to selectively target toxic amyloid-beta oligomers while avoiding plaque binding, an approach intended to reduce off-target effects associated with plaque-directed therapies.
- ProMIS expects to report blinded 6-month interim data from its fully enrolled PRECISE-AD Phase 1b trial in early Q3 2026, with 12-month topline data anticipated in early 2027.
- Within days of ProMIS's announcement, Pattern Group Inc. , Sabre Corporation , and Amphastar Pharmaceuticals announced investor conference participation, reflecting broader industry engagement on clinical and business developments.
26 Articles
26 Articles
Brampton Guardian
ProMIS Neurosciences to Participate in Upcoming Conferences in June
CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today announced that it will participate in upcoming June 2026 conferences,…
Nektar Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference in New York
SAN FRANCISCO, May 27, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that company management will be webcasting its participation in the 2026 Jefferies Global Healthcare Conference being held June 2-4, 2026 in New York.
Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference
RANCHO CUCAMONGA, CA / ACCESS Newswire / May 27, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will be presenting at the 2026 Jefferies Healthcare Conference on Wednesday, June…
Satellos to Participate in Upcoming Investor Conferences
TORONTO, May 27, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today announced that members of the Company management team will…
Coverage Details
Bias Distribution
- 44% of the sources lean Left, 44% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium